We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 68.50 | 67.00 | 70.00 | 68.50 | 67.00 | 68.50 | 3,493 | 08:00:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -5.22 | 16.15M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/4/2020 08:46 | Wakey wakey hands of snakey ? | the stigologist | |
30/4/2020 03:05 | $PDSB news overnight | the stigologist | |
29/4/2020 22:56 | You a crazy fool This was a spike like PYC did today Both willNeed to fall back to sub 2p levels before the pumpers will find aNew angle to pump the stock | iamgreat1 | |
29/4/2020 17:35 | My average is 6.5p. Now I'm going to try and hold for the expected 30p, minimum. | clive talking | |
29/4/2020 13:27 | Bizarre - people who wouldn't buy at 6p are now paying 9.35p for the same Wonder if it's iamgreat1 buying back his soiled shorts? | topnotch | |
29/4/2020 12:01 | nice cash position: Cash and cash equivalents at HQ and portfolio companies of £3.5 million | euclid5 | |
29/4/2020 09:26 | escapetohome >> for someone who has no vested interest here, you seem to waste a disproportionate amount of time posting pointless, negative comments about it | topnotch | |
28/4/2020 13:50 | Well that's good to hear. Wouldn't be at all surprised if this one quickly rallies 10p from here.. | clive talking | |
28/4/2020 13:44 | But im really pleased with my avacta holding,the gains on that have balanced out my covid loss. So overall my portfolio is showing no overall loss at the moment, due to covid. | escapetohome | |
28/4/2020 13:42 | £0 clive. Ive never shorted an individual stock. I bought some vilx before the covid outbreak and made around 180% , when that black swan event happened. But i havent got back in to that yet. There is some unusual strength in these markets. | escapetohome | |
28/4/2020 13:27 | Will you tell us how much you've won from your bet shorting this then? | clive talking | |
28/4/2020 10:30 | Now all you need is delisting RNS. And this will be a pittance. | escapetohome | |
28/4/2020 10:29 | Oh dear!!! Looks my like TIMBER advice was spot on. Very very apt. | escapetohome | |
28/4/2020 09:31 | Silly games going on here... | garth | |
27/4/2020 14:57 | Interesting they actually mentioned ProAxsis covid19 opportunities | the stigologist | |
24/4/2020 17:23 | Feels like the Virus has left | rosco230667 | |
24/4/2020 15:59 | Shame as empty bubbles like this keep rising and real investments like UFO alien metals are stagnant | akmal101 | |
24/4/2020 15:17 | Iamgreat reported for deramping. Report derampers to below | adnexal schevsur | |
24/4/2020 11:02 | :0) It is new for me. Been doing some digging the last couple of days. So, OT then, but not far off: Cash burn rate isn't too bad. Their "NXP002" is based on Tranilast. Tranilast directly targets NLRP3 to treat inflammasome‐d Ergo... Maybe 2=2=4, or maybe it doesn't. I have taken a position on the basis that it often does. No comment in that regard from the company yet. The underlying business looks undervalued to me with the low burn giving reassurance. Makes it all look a bit of a no-brainer in the wider context of my portfolio. That makes NSCI and NFX my bio/pharma positions. Not advice - DYOR. G. | garth | |
24/4/2020 10:52 | NFX never rated it. Seems far too promotional. A turn off. | the stigologist | |
24/4/2020 10:52 | Jonah someone who brings bad luck | the stigologist | |
24/4/2020 10:51 | NFX looks interesting chartwise - will add to my watchlist Thanks - and for the explanation also | topnotch |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions